Caspase 6 regulates B cell activation and differentiation into plasma cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Caspase proteases are crucial regulators of lymphocyte apoptosis, activation, and development.
• The specific role of Caspase-6 (Casp6) in B cell function remains incompletely understood.

Purpose of the Study:

• To investigate the role of Caspase-6 (Casp6) in regulating B cell activation and differentiation.
• To elucidate the impact of Casp6 deficiency on B cell cycle entry and plasma cell development.

Main Methods:

• Analysis of B cells from Caspase-6 knockout (Casp6 KO) and wild-type (WT) mice.
• Flow cytometry to assess cell cycle distribution (G1, S phase).
• Measurement of B cell proliferation, plasma cell differentiation (syndecan-1 expression), and antibody production (IgG isotypes, antigen-specific responses).

Main Results:

• Casp6 KO B cells exhibit accelerated entry into G1 phase compared to WT B cells.
• Despite faster G1 entry, Casp6 KO B cells do not show increased proliferation but preferentially differentiate into syndecan-1(+) plasma cells.
• Casp6 KO mice display elevated serum IgG1, IgG2a, IgG2b levels and enhanced antigen-specific antibody responses, correlating with increased plasma cell percentages.

Conclusions:

• Caspase-6 (Casp6) plays a significant role in modulating B cell activation and differentiation into antibody-producing plasma cells.
• Casp6 appears to regulate the transition of quiescent (G0) B cells into the active (G1) phase, influencing their subsequent fate towards differentiation rather than proliferation.
• Targeting Casp6 could represent a therapeutic strategy for enhancing humoral immune responses.